Notice Pursuant to the National Cooperative Research and Production Act of 1993-Pistoia Alliance, Inc., 34364 [E9-16697]
Download as PDF
<![CDATA[
34364
Federal Register / Vol. 74, No. 134 / Wednesday, July 15, 2009 / Notices
Fluid Controls, Mississauga, Ontario,
Canada; Moog, East Aurora, IL; National
Fluid Power Association, Milwaukee,
WI; Pall Aeropower, Fort Myers, FL;
Parker Hannif in, Cleveland, OH;
Poclain Hydraulics, Sturtevant, WI;
Quality Control, Chicago, IL; ROSS
Controls, Troy, MI; Sauer-Danfoss,
Ames, IA; Schmalz, Raleigh, NC; and
Sun Hydraulics, Sarasota, FL.
The general area of NFPA’s planned
activity is the joint development of an
action plan to identify and prioritize
research and development projects in
the fluid power industry, specifically,
research investments, capability
developments, and skills acquisitions
needed to achieve advancement in
hydraulics and pneumatics technology
to meet future fluid power needs. For
more information concerning the joint
activities, please contact Eric Lanke,
CAE, Executive Director of the National
Fluid Power Association at 3333 N.
Mayfair Rd., Suite 211, Milwaukee, WI
53222.
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. E9–16688 Filed 7–14–09; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Namur, BELGIUM; The Edge Software
Consultancy Ltd., Guildford, Surrey,
UNITED KINGDOM; and GGA Software
Services LLC, Cambridge, MA.
The general area(s) of Pistoia Alliance,
Inc.’s planned activity are to: (a)
Streamline non-competitive elements of
the pharmaceutical drug discovery
workflow by the specification of
common business terms, relationships
and processes and to facilitate the
development and adoption of open,
accessible data standards, taxonomies,
ontologies and Web-service descriptions
(the ‘‘Specifications’’); (b) promote such
specifications and solutions worldwide;
(c) provide for testing and conformity
assessment of implementations in order
to ensure and/or facilitate compliance
with Specifications; (d) operate a
branding program based upon
distinctive trademarks to create high
customer awareness of, demand for, and
confidence in products designed in
compliance with Specifications; and (e)
undertake such other activities as may
from time to time be appropriate to
further the purposes and achieve the
goals set forth above.
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. E9–16697 Filed 7–14–09; 8:45 am]
BILLING CODE 4410–11–M
Antitrust Division
sroberts on DSKD5P82C1PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Pistoia Alliance, Inc.
DEPARTMENT OF JUSTICE
Notice is hereby given that, on May
28, 2009, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Pistoia Alliance, Inc.
has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing (1) the identities
of the parties to the venture and (2) the
nature and objectives of the venture.
The notifications were filed for the
purpose of invoking the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Pursuant to Section 6(b) of the Act,
the identities of the parties to the
venture are: Novartis Institutes for
BioMedical Research, Inc., Cambridge,
MA; AstraZeneca UK Limited,
Westminster, London, UNITED
KINGDOM; Glaxo Group, Ltd.,
Brentford, Middlesex, UNITED
KINGDOM; Pfizer, Inc., New York, NY;
Accelrys Inc., San Diego, CA;
ChemlTment, Amston, CT; ChemAxon
Ltd., Budapest, HUNGARY; BioXpr,
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—DVD Copy Control
Association
VerDate Nov<24>2008
17:21 Jul 14, 2009
Jkt 217001
Antitrust Division
Notice is hereby given that, on June 5,
2009, pursuant to Section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), DVD Copy Control
Association (‘‘DVD CCA’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Continental Automotive GmbH,
Wetzlar, GERMANY; DVS Korea Co.,
Ltd., Kyungi-do, REPUBLIC OF KOREA;
East European Authoring and Encoding
Centre Ltd., Sofia, BULGARIA; Ever
Best Industrial (H.K.) Limited, Kowloon,
HONG KONG–CHINA; Everbest
Technology Development Ltd., North
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Point, HONG KONG–CHINA; Forworid
Electronics Co., Ltd., Taichung City,
TAIWAN; Hong Kong ASA Multimedia
Co., Ltd., Kowloon, HONG KONG–
CHINA; Orbit Corporation, Los Angeles,
CA; Tecunion Electronics Technology
Ltd., Shenzhen, PEOPLE’S REPUBLIC
OF CHINA; Ultra Source Technology
Corp., Hong Kong, HONG KONG–
CHINA; Unicorn Information Systems
Co., Ltd., Seoul, REPUBLIC OF KOREA;
Willette Acquisition Corp. dba Allied
Vaughn, Minneapolis, MN; and
Zhejiang Tianle Digital Electric Co.,
Ltd., Zhejiang, PEOPLE’S REPUBLIC OF
CHINA have been added as parties to
this venture.
Also, Beautiful Enterprise Co., Ltd.,
Kowloon, HONG KONGCHINA; Cinea,
Inc., Richmond, VA; Dicentia A/S,
Sakskobing, DENMARK; Evatone, Inc.,
Clearwater, FL; Hewlett-Packard
Company, Cupertino, CA; KalosNett Co.,
Ltd., Seoul, REPUBLIC OF KOREA;
Kawai Musical Instruments Nfg. Co.,
Ltd., Shizouka, JAPAN; New York
Nickel LLC, Bohemia, NY; Pinnacle
Systems, GmbH, Braunschweig,
GERMANY; Protect Software GmbH,
Dortmund, GERMANY; Protocall
Technologies Incorporated, Commack,
NY; ScientificAtlanta, Inc.,
Lawrenceville, GA; and Zhongshan
Tomel Audio & Video Products Co.,
Ltd., Guangdong, PEOPLE’S REPUBLIC
OF CHINA have withdrawn as parties to
this venture. In addition, Homenema
Disk Inc. has changed its name to
Homenema Technology Inc., Taipei
Hsien, TAIWAN.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and DVD CCA
intends to file additional written
notifications disclosing all changes in
membership.
On April 11, 2001, DVD CCA filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on August 3, 2001 (66 FR 40727).
The last notification was filed with
the Department on March 6, 2009. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on April 20, 2009 (74 FR 17985).
Patricia A. Brink,
Deputy Director of Operations, Antitrust
Division.
[FR Doc. E9–16698 Filed 7–14–09; 8:45 am]
BILLING CODE 4410–11–M
E:\FR\FM\15JYN1.SGM
15JYN1
]]>Agencies
[Federal Register Volume 74, Number 134 (Wednesday, July 15, 2009)]
[Notices]
[Page 34364]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16697]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Pistoia Alliance, Inc.
Notice is hereby given that, on May 28, 2009, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Pistoia Alliance, Inc. has filed
written notifications simultaneously with the Attorney General and the
Federal Trade Commission disclosing (1) the identities of the parties
to the venture and (2) the nature and objectives of the venture. The
notifications were filed for the purpose of invoking the Act's
provisions limiting the recovery of antitrust plaintiffs to actual
damages under specified circumstances.
Pursuant to Section 6(b) of the Act, the identities of the parties
to the venture are: Novartis Institutes for BioMedical Research, Inc.,
Cambridge, MA; AstraZeneca UK Limited, Westminster, London, UNITED
KINGDOM; Glaxo Group, Ltd., Brentford, Middlesex, UNITED KINGDOM;
Pfizer, Inc., New York, NY; Accelrys Inc., San Diego, CA; ChemlTment,
Amston, CT; ChemAxon Ltd., Budapest, HUNGARY; BioXpr, Namur, BELGIUM;
The Edge Software Consultancy Ltd., Guildford, Surrey, UNITED KINGDOM;
and GGA Software Services LLC, Cambridge, MA.
The general area(s) of Pistoia Alliance, Inc.'s planned activity
are to: (a) Streamline non-competitive elements of the pharmaceutical
drug discovery workflow by the specification of common business terms,
relationships and processes and to facilitate the development and
adoption of open, accessible data standards, taxonomies, ontologies and
Web-service descriptions (the ``Specifications''); (b) promote such
specifications and solutions worldwide; (c) provide for testing and
conformity assessment of implementations in order to ensure and/or
facilitate compliance with Specifications; (d) operate a branding
program based upon distinctive trademarks to create high customer
awareness of, demand for, and confidence in products designed in
compliance with Specifications; and (e) undertake such other activities
as may from time to time be appropriate to further the purposes and
achieve the goals set forth above.
Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. E9-16697 Filed 7-14-09; 8:45 am]
BILLING CODE 4410-11-M
